XLV Stock Recent News
XLV LATEST HEADLINES
Look at ETFs to safeguard your portfolio as declining consumer confidence, sluggish growth and persistent inflationary pressures increase the likelihood of the U.S. economy slipping into a recession in 2025.
Talk about a topsy-turvy market. Tuesday's tariffs sparked more market jitters.
Wall Street has been in a wavering condition lately as U.S. economic data heightened investor fears of a slowing economy and persistent inflation. This prompted a shift toward safer assets.
The Investment Committee discuss some of their stocks that are moving today.
Investors cooled to the healthcare sector in 2024, which dramatically trailed global and US equity markets for the year. any investors are now asking: how will the policy changes under a new US administration affect healthcare companies?
THW: NAV Growth Starting To Improve
The 'Undercovered' Dozen series highlights 12 lesser-known ETFs offering potential investment opportunities for investors. Kurtis Hemmerling shares a bearish take on iShares Russell Top 200 Growth ETF due to poor factor implementation, despite its strong historical performance. Goldman Sachs Nasdaq-100 Core Premium Income ETF is given a buy from Jonathan Weber for income-oriented investors, combining a 10% dividend yield with tech exposure.
The final trades of the day with CNBC's Melissa Lee and the Fast Money traders.
Here are some of the recent references I have made about Biotechnology Sector (IBB) and the potential for a rally. Incidentally, Moderna (MRNA) is so oversold on a monthly timeframe, it should be on your radar.
With President Trump introducing tariffs on China and China responding with retaliatory tariffs, the possibility of a trade war increases. Look at ETFs to play a defensive strategy to navigate through this uncertainty.